Hasil Pencarian - Henry Conter
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 4 hasil dari 4
-
1
-
2
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage... oleh Arif Awan, Terry Ng, Henry Conter, William Raskin, Carol Stober, Demetrios Simos, Greg Pond, Sukhbinder Dhesy-Thind, Mihaela Mates, Vikaash Kumar, Dean Fergusson, Brian Hutton, Deanna Saunders, Lisa Vandermeer, Mark Clemons
Diterbitkan 2021-02-01
Artikel -
3
347 KEYNOTE-365 cohort C: pembrolizumab + enzalutamide in patients with abiraterone acetate–pretreated metastatic castration-resistant prostate cancer (mCRPC)—data after minimum of... oleh Urban Emmenegger, Howard Gurney, Emanuela Romano, Neal Shore, Margitta Retz, Christian Poehlein, Charles Schloss, Leonard Appleman, Gwenaelle Gravis, Loïc Mourey, Josep Piulats, Evan Yu, Johann De Bono, William Berry, Peter Fong, Cristiano Ferrario, Tilman Todenhoefer, Henry Conter, Brigitte Laguerre, Xin Tong Li
Diterbitkan 2021-11-01Artikel -
4
351 KEYNOTE-365 cohort D: pembrolizumab plus abiraterone acetate and prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) oleh Urban Emmenegger, Christian Poehlein, Charles Schloss, Leonard Appleman, Loïc Mourey, Anthony Joshua, Mark Linch, Josep Piulats, Evan Yu, Johann De Bono, William Berry, Peter Fong, Cristiano Ferrario, Tilman Todenhoefer, Henry Conter, Brigitte Laguerre, Xin Tong Li, Michael Stoeckle, Jose Arranz, Nataliya Mar
Diterbitkan 2021-11-01Artikel